Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha. Multicenter Interferon Beta Italian Group Investigators - Barbaro, G; Di Lorenzo, G; Soldini, M; Giancaspro, G; Pellicelli, A; Grisorio, B (Scand J Gastroenterol, 1999)
et al.